Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-009 (nab-sirolimus) in NMIBC
NCT02009332Phase 2Completed
- Sponsor
- Aadi Bioscience, Inc.
- Start
- Apr 2014
- Primary completion
- Dec 2019
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-sirolimus in non-muscle-invasive bladder cancer (NMIBC), sponsored by Aadi Bioscience, Inc.. Started Apr 2014; status: completed.
02
Drugs
nab-sirolimus
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT02009332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009332.